6.01
Schlusskurs vom Vortag:
$6.24
Offen:
$6.2
24-Stunden-Volumen:
1.27M
Relative Volume:
0.88
Marktkapitalisierung:
$926.32M
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-5.4144
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+1.01%
1M Leistung:
-18.12%
6M Leistung:
-60.20%
1J Leistung:
-2.59%
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
WVE
Wave Life Sciences Ltd
|
6.01 | 917.10M | 53.61M | -142.52M | -141.83M | -1.11 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-08 | Eingeleitet | Wedbush | Outperform |
2025-02-25 | Eingeleitet | Jefferies | Buy |
2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
2024-09-09 | Eingeleitet | JP Morgan | Overweight |
2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2023-07-05 | Eingeleitet | Raymond James | Outperform |
2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | Eingeleitet | Guggenheim | Buy |
2019-07-15 | Eingeleitet | Cowen | Market Perform |
2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
2018-08-07 | Eingeleitet | Stifel | Buy |
2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
2018-03-19 | Bestätigt | Mizuho | Buy |
2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
2015-12-07 | Eingeleitet | Jefferies | Buy |
2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Nuveen Asset Management LLC Has $6.85 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference | WVE Stock News - GuruFocus
Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewswire
Wave Life Sciences CEO Reveals Next-Gen RNA Medicine Plans at Major Healthcare Conference - Stock Titan
Wave Life Sciences Announces Appointment Of Dr. Christopher Wright As Chief Medical Officer - marketscreener.com
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WV - GuruFocus
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire
Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WVE Stock News - GuruFocus
Harvard Professor to Chief Medical Officer: Wave Life Sciences Taps RNA Expert Behind Breakthrough FDA Approvals - Stock Titan
WaVe Life Sciences’ SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Nigeria
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $648,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Bank of America Corp DE Acquires 160,820 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Deutsche Bank AG Purchases 25,756 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? - MSN
BNP Paribas Financial Markets Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of “Buy” by Analysts - Defense World
Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Increased by Northern Trust Corp - Defense World
(WVE) On The My Stocks Page - news.stocktradersdaily.com
FY2025 Earnings Estimate for WVE Issued By Cantor Fitzgerald - Defense World
Raymond James Financial Inc. Takes $157,000 Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com Australia
H.C. Wainwright maintains $22 target on WAVE Life Sciences stock By Investing.com - Investing.com India
Wave Life Sciences (NASDAQ:WVE) Stock Rating Lowered by StockNews.com - Defense World
Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com
Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks
Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register
WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus
Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo
Wave Life Sciences (WVE) Misses Revenue Estimates, Advances Clinical Trials | WVE Stock News - GuruFocus
Wave Life Sciences Reports Q1 2025 Financial Results - TipRanks
WAVE LIFE SCIENCES Earnings Results: $WVE Reports Quarterly Earnings - Nasdaq
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Earnings Flash (WVE) Wave Life Sciences Reports Q1 Revenue $9.2M, vs. FactSet Est of $11.9M - marketscreener.com
WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Kno - GuruFocus
WAVE Life Sciences Earnings Preview - Nasdaq
WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Closing Figures: Wave Life Sciences Ltd (WVE)’s Negative Finish at 6.41, Down -17.08 - DWinneX
Wave Life Sciences (WVE) Projected to Post Earnings on Thursday - Defense World
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):